Stay informed with the latest updates for the inheritable blood disorders community.

NBDF & Community
NHF Partners with BCS Financial
NHF Partners with BCS Financial
Industry
1174384721-doses
Pfizer Announces First Participant Dosed Phase 3 Study of Marstacimab
Industry
1242454551-Medical-Trial
uniQure Announces Positive Results from Phase 3 Gene Therapy Trial
Medical
899906850 Online Activity
New Medscape Activity Includes Latest Gene Therapy Clinical Trial Updates…
Medical
A Great Opportunity to Learn More About Rare Platelet and Bleeding…
Medical
Small Study Looks at Use of Epidural Analgesia During Labor in VWD Type 1
Small Study Looks at Use of Epidural Analgesia During Labor in VWD Type 1…
NBDF & Community
Since 1972, we have been supporting basic science and pre-clinical research to expand our understanding of bleeding disorders.
Supporting the Judith Graham Pool Fellowship
Medical
First National HTC Patient Satisfaction Survey: The Results Are In
First National HTC Patient Satisfaction Survey: The Results Are In
COVID-19
COVID-19 Vaccines: What to Expect
COVID-19 Vaccines: What to Expect
Peer-Reviewed Journal Summaries
The First National Patient Satisfaction Survey of U.S. HTCs
The First National Patient Satisfaction Survey of U.S. HTCs
NBDF & Community
Access the World's Largest Hemophilia Repository
Access the World's Largest Hemophilia Repository
Industry
Global Dosing Hold in Fitusiran Trials Initiated by Sanofi Genzyme to Investigate New Adverse Events
Global Dosing Hold in Fitusiran Trials Initiated…
COVID-19
Register for COVID-19 Vaccines: What to Expect
Register for COVID-19 Vaccines: What to Expect
Press Releases
With Patient Perspectives in Mind, ICER Evaluates Hemophilia Therapies
With Patient Perspectives in Mind, ICER Evaluates Hemophilia Therapies
NBDF & Community
Highlights from NHF's Virtual Insurance and Reimbursement Conference
Highlights from NHF's Virtual Insurance and Reimbursement Conference